|
2024
|
Invention
|
Mass spectrometric analysis. Isotopic mass tags for labelling peptides and other biomolecules are... |
|
2017
|
Invention
|
Mass spectrometric quantitation. Provided is a method of assaying for an analyte, including combi... |
|
2016
|
Invention
|
Isobaric mass labels having n',n'-dimeihyl piperazine-2-carboxylic acid reporter moieties.
where... |
|
|
Invention
|
Isobaric mass labels.
wherein X is a reporter moiety having an exact mass, L is a bond cleavable... |
|
|
Invention
|
Isobaric mass labels. The present invention relates to a set of two or more mass labels, wherein ... |
|
|
Invention
|
Isotopic methods for measurement of tryptophan and metabolites thereof. Tryptophan degradation is... |
|
|
Invention
|
Casein kinase 1delta (ck 1delta) inhibitors and their use in the treatment of neurodegenerative d... |
|
|
Invention
|
Biomolecules involved in alzheimer's disease.
The invention relates to panels of biomarkers incl... |
|
|
Invention
|
Biomolecules involved in alzheimer's disease. The invention relates to panels of biomarkers inclu... |
|
|
Invention
|
Casein kinase 1 delta inhibitor. The present invention provides 2-Methyl-amino-3-[(4-fluorophenyl... |
|
|
Invention
|
A casein kinase 1 delta inhibitor. The present invention provides 2-Methyl-amino-3-[(4-fluorophen... |
|
|
Invention
|
Materials and methods for diagnosis and treatment of alzheimer's disease. Alzheimer's disease (AD... |
|
|
Invention
|
Materials and methods for diagnosis and treatment of alzheimer's disease. Alzheimer's disease, th... |
|
2015
|
Invention
|
Casein kinase 1delta (ck1delta) inhibitors. The invention relates to pharmaceutical compositions ... |
|
|
Invention
|
Isobaric mass labels. The present invention relates to a set of two or more mass labels. Each mas... |
|
|
Invention
|
Mass spectrometric quantitation.
Provided is a method of assaying for an analyte, including comb... |
|
|
Invention
|
Casein kinase 1δ (ck 1δ) inhibitors. The invention relates to pharmaceutical compositions having ... |
|
2014
|
Invention
|
Mass labels. 2 of the bifunctional linker attached to the analyte reacts with a mass label to for... |
|
|
Invention
|
Mass labels and methods of use thereof for labelling analytes. The present invention provides a m... |
|
|
Invention
|
Mass labels. The present invention provides a method for labelling one or more analytes in a samp... |
|
|
Invention
|
Biomarkers and methods relating to alzheimer's disease.
Alzheimer's disease, the most common cau... |
|
|
Invention
|
Biomarkers and methods relating to alzheimer's disease. Alzheimer's disease, the most common caus... |
|
|
Invention
|
Materials and methods for diagnosis and prognosis of liver cancer.
The invention relates to mate... |
|
|
Invention
|
Materials and methods for diagnosis and prognosis of liver cancer. The invention relates to mater... |
|
|
Invention
|
Mass labels.
A reactive mass label for labelling a biological molecule for detection by mass spe... |
|
|
Invention
|
Materials and methods relating to pancreatic cancer.
The present invention concerns materials an... |
|
|
Invention
|
Materials and methods relating to pancreatic cancer. The present invention concerns materials and... |
|
|
Invention
|
Methods and compositions relating to neurodegenerative diseases.
The present invention provides ... |
|
|
Invention
|
Methods and compositions relating to neurodegenerative diseases. The present invention provides a... |
|
|
Invention
|
Materials and methods relating to alzheimer's disease.
The invention relates to methods and comp... |
|
|
Invention
|
Materials and methods relating to alzheimer's disease. The invention relates to methods and compo... |
|
|
Invention
|
Mass labels.
The present invention provides set of two or more mass labels, wherein each mass la... |
|
|
Invention
|
Mass labels. The present invention provides set of two or more mass labels, wherein each mass lab... |
|
2012
|
Invention
|
Materials and methods for determining sensitivity potential of compounds.
The invention concerns... |
|
|
G/S
|
Scientific and technological services, namely, research and design in the field of proteomics; sc... |
|
|
G/S
|
scientific and technological services, namely, research and analysis in the field of proteomics; ... |
|
|
G/S
|
Scientific and technological services and research and
design relating thereto; industrial analy... |
|
|
G/S
|
Chemicals for use in industry; chemicals, namely, buffer and
standard solutions used in analytic... |
|
|
G/S
|
Scientific and technological services and research and design relating thereto; industrial analys... |
|
2004
|
G/S
|
Chemical reagents for scientific research use, namely for the labelling of biomolecules, proteins... |
|
|
G/S
|
Reagents for scientific or research use; reagents for medical or veterinary research use; clinica... |
|
|
G/S
|
Chemical reagents (not for medicinal or veterinary use);
in-vitro-diagnostics (not for medicinal... |
|
2003
|
G/S
|
Chemical reagents for scientific research use, namely, for the labelling of biomolecules, protein... |
|
|
G/S
|
Chemical reagents (other than for medical or veterinary purposes); in-vitro diagnostics (not for ... |
|
2001
|
G/S
|
Kits containing chemicals, reagents, for the disruption of cells, tissues or other biological mat... |
|
|
G/S
|
Development of processes, programs, products, apparatus and
instruments relating to assays for t... |
|
|
G/S
|
Chemical, biological and medical analysis for third parties. |
|
|
G/S
|
Chemical, biological and medical analysis of proteins, peptides and glucoproteins for third parti... |
